home / stock / avcnf / avcnf quote
Last: | $0.2806 |
---|---|
Change Percent: | 6.02% |
Open: | $0.2825 |
Close: | $0.2806 |
High: | $0.2825 |
Low: | $0.2806 |
Volume: | 6,000 |
Last Trade Date Time: | 04/25/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.2806 | $0.2825 | $0.2806 | $0.2825 | $0.2806 | 6,000 | 04-25-2024 |
$0.3006 | $0 | $0.3006 | $0 | $0 | 5,300 | 04-24-2024 |
$0.3006 | $0 | $0.3006 | $0 | $0 | 11,550 | 04-22-2024 |
$0.3006 | $0 | $0.3006 | $0 | $0 | 2,500 | 04-19-2024 |
$0.3006 | $0.29 | $0.3006 | $0.3006 | $0.29 | 5,600 | 04-18-2024 |
$0.2295 | $0 | $0.2295 | $0 | $0 | 18,500 | 04-17-2024 |
$0.2295 | $0.2497 | $0.2295 | $0.2497 | $0.2295 | 5,500 | 04-16-2024 |
$0.28815 | $0 | $0.28815 | $0 | $0 | 4,500 | 04-15-2024 |
$0.28815 | $0.28815 | $0.28815 | $0.28815 | $0.28815 | 9,101 | 04-12-2024 |
$0.317 | $0.296 | $0.317 | $0.31825 | $0.296 | 9,502 | 04-11-2024 |
$0.295 | $0.295 | $0.295 | $0.295 | $0.295 | 12,308 | 04-10-2024 |
$0.2947 | $0.3021 | $0.2947 | $0.3021 | $0.2947 | 9,677 | 04-09-2024 |
$0.3021 | $0.3021 | $0.3021 | $0.3021 | $0.3021 | 7,150 | 04-08-2024 |
$0.34488 | $0.34488 | $0.34488 | $0.34488 | $0.34488 | 250 | 04-05-2024 |
$0.32555 | $0.337 | $0.32555 | $0.3398 | $0.32555 | 5,750 | 04-04-2024 |
$0.3628 | $0.3432 | $0.3628 | $0.3628 | $0.3361 | 6,598 | 04-03-2024 |
$0.3618 | $0.39 | $0.3618 | $0.39 | $0.3611 | 3,512 | 04-02-2024 |
$0.4 | $0.3639 | $0.4 | $0.4 | $0.3612 | 18,750 | 04-01-2024 |
$0.3916 | $0.3768 | $0.3916 | $0.3916 | $0.3768 | 10,006 | 03-29-2024 |
$0.3916 | $0.3768 | $0.3916 | $0.3916 | $0.3768 | 10,006 | 03-28-2024 |
News, Short Squeeze, Breakout and More Instantly...
Avicanna Inc Company Name:
AVCNF Stock Symbol:
OTCMKTS Market:
TORONTO, April 18, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. ("Avicanna" or the "Company") (TSX:AVCN) (OTCQX:AVCNF) (FSE: 0NN) a biopharmaceutical ...
TORONTO, April 18, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or the “ Company ”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based pro...
TORONTO, April 10, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or the “ Company ”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based pro...